Events

DIA Europe 2025
MAR
Tue
18
MAR
Wed
19
MAR
Thu
20

This was 3 months ago

Location

Basel, Switzerland

Programmes
Health

DIA Europe is a conference for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape

DIA Europe 2025 will focus on transforming insights into action by bridging the gap between critical policy discussions and real-world expertise. This year will include many different session formats that allow participants to do a deep-dive on preferred topics. ​

Several of the sessions included in the programme feature speakers from the European Medicines Agency. 

More information, the detailed programme and registration on the event websitePlease be aware this is a paying event. Please make sure to check the ticket price for your stakeholder category before registry.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.